Annexon, Inc. - COMMON STOCK (ANNX)

CUSIP: 03589W102

Q4 2023 13F Holders as of 31 Dec 2023

Holder snapshot 7 signals
Share change
+26,436,657
Put/Call ratio
112%
SEC-reported price per share
$4.54
Number of holders
98
Value change
+$125,501,716
Number of buys
53
Open additional details 1 more signal available
Number of sells
39
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
163,738,683

Security key

03589W102

Report period

Q4 2023

Institutions

98

Top holders

10

Ownership snapshot

Top reported holders of ANNX - Annexon, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Bain Capital Life Science...
Disclosed value leader
Bain Capital Life Science...
Comparable rows
0/15
Latest evidence
30 Sep 2023
3/4/5 13F Highest disclosed value: $24,428,590 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Bain Capital Life Sciences Investors, LLC has the largest disclosed position value at $24.43M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Bain Capital Life Sciences Investors, LLC's linked filing trail.
Disclosed position value Top 5
Bain Capital Life Sciences Invest... $24.43M
Alerce Investment Management, L.P. $16.65M
Logos Global Management LP $12.51M
Redmile Group, LLC $8.27M
BlackRock Finance, Inc. $8.04M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Bain Capital Life Sciences Investors, LLC
3/4/5 13F
10%+ Owner · Company
—
denominator unverified
$24,428,590
5,401,926 shares
— 25 May 2023
Alerce Investment Management, L.P.
13F
Company
13F
—
denominator unverified
$16,652,217
7,056,024 shares
— 30 Sep 2023
Logos Global Management LP
13F
Company
13F
—
denominator unverified
$12,508,000
5,300,000 shares
— 30 Sep 2023
Redmile Group, LLC
13F
Company
13F
—
denominator unverified
$8,267,528
3,503,190 shares
— 30 Sep 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$8,042,854
3,407,989 shares
— 30 Sep 2023
GMT CAPITAL CORP
13F
Company
13F
—
denominator unverified
$6,632,712
2,810,471 shares
— 30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
98
Shares
80,514,496
Rows available
98
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
91
Q4 2023 holders
98
Holder diff
7
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .